STAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate case
↗California Supreme Court ruled in favor of Gilead in a duty-to-innovate case, potentially easing liability risk for slow-walking drug development while underscoring industry concern about how litigation could influence R&D decisions.
Aug 4, 20261%